What is Norac Pharma?
Norac Pharma operates as a premier contractor focused on process research and development (R&D) and the supply of active pharmaceutical ingredients (APIs). The company provides a comprehensive suite of services, including API R&D, analytical R&D, API manufacturing, and preclinical support, all facilitated by advanced, state-of-the-art facilities. Renowned for its stringent adherence to environmental, health, and safety standards, Norac Pharma has been recognized with the SOCMA National Performance Improvement Honor. The company targets pharmaceutical firms seeking collaborative partnerships for pioneering chemistry solutions and dependable API sourcing.
How much funding has Norac Pharma raised?
Norac Pharma has raised a total of $2M across 1 funding round:
Debt
$2M
Debt (2020): $2M with participation from PPP
Key Investors in Norac Pharma
PPP
Public-Private Partnership
What's next for Norac Pharma?
The recent major strategic investment positions Norac Pharma for accelerated expansion and enhanced service offerings. This capital infusion is expected to fuel advancements in their R&D capabilities and manufacturing capacity, enabling them to forge deeper partnerships within the pharmaceutical sector. Norac Pharma's commitment to quality and innovation, coupled with this significant backing, suggests a strategic push to solidify its role as a key player in API development and supply.
See full Norac Pharma company page
